INHIBITION OF BASAL AND METOCLOPRAMIDE-INDUCED PROLACTIN-RELEASE BY CABERGOLINE, AN EXTREMELY LONG-ACTING DOPAMINERGIC DRUG

被引：18

作者：

PONTIROLI, AE

CAMMELLI, L

BAROLDI, P

POZZA, G

机构：

[1] FARMITALIA CARLO ERBA RES & DEV, MILAN, ITALY

[2] UNIV MILAN, CATTEDRA CLIN MED, IST SCI SAN RAFFAELE, I-20122 MILAN, ITALY

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1987年 / 65卷 / 05期

关键词：

D O I：

10.1210/jcem-65-5-1057

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1057 / 1059

页数：3

相关论文

共 12 条

[1] DECECCO L, 1978, CLIN ENDOCRINOL, V9, P491
[2] DELPOZO E, 1972, J CLIN ENDOCR METAB, V35, P768, DOI 10.1210/jcem-35-5-768
[3] DISALLE E, 1983, ACTA ENDOCR-COP S256, V103, P265
[4] DISALLE E, 1984, 1ST S EUR NEUR ASS B, P122
[5] DISALLE E, 1982, J ENDOCRINOL INVE S1, V5, P45
[6] DISALLE E, 1984, J ENDOCRINOL INVE S1, V7, P32
[7] DISALLE E, 1983, J ENDOCRINOL INVE S1, V6, P6
[8] ENDOCRINE PROFILE AND THERAPEUTIC EMPLOYMENT OF A NEW PROLACTIN-LOWERING DRUG, METERGOLINE
FERRARI, C
RESCHINI, E
PERACCHI, M
CROSIGNANI, PG
[J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1980, 11 (01) : 1 - 16
[9] LONG-LASTING PROLACTIN-LOWERING EFFECT OF CABERGOLINE, A NEW DOPAMINE AGONIST, IN HYPERPROLACTINEMIC PATIENTS
FERRARI, C
BARBIERI, C
CALDARA, R
MUCCI, M
CODECASA, F
PARACCHI, A
ROMANO, C
BOGHEN, M
DUBINI, A
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (04) : 941 - 945
[10] DOSE-DEPENDENCY AND REPRODUCIBILITY OF THE PROLACTIN RESPONSE TO METOCLOPRAMIDE
KITAOKA, M
TAKEBE, K
KOBAYASHI, M
NAKAZONO, M
KUDO, M
[J]. HORMONE AND METABOLIC RESEARCH, 1980, 12 (04) : 155 - 158